Skip to primary content

Skip to secondary content

Biotech 365

Search

Main menu

Biotech 365
Companies
Healthcare Investors
- Healthcare LPs
Healthcare Investors Matchmaking
Free DEMO
Services
Contact

Tag Archives: preclinical evaluation of anticancer therapies

Oncodesign – preclinical evaluation of anticancer therapies

Posted on by

Oncodesign is a biotech company offering preclinical evaluation of anticancer therapies (Pharmimage, PREDICT, Chi-Mice, Nanocyclix, etc…).

Oncodesign – preclinical evaluation of anticancer therapies

Continue reading →

Posted in Biotech Companies, Biotech Companies France | Tagged anticancer therapies, anticancer therapy, biomarker, biomarker development, Chi-Mice, drug combination, drug formulation, eADMET, early ADMET, early ADMET model, early ADMET models, human kinome, imaging biomarker development, Jean-Marie Charpin, Kamel Boumali, kinase inhibitors, Nanocyclix, Nanokinib, Oncodesign, Oncodesign - preclinical evaluation of anticancer therapies, Oncodesign Biotech, Oncodesign Biotechnology, Pharm Image, pharmaco-imaging, pharmaco-imaging platform, PharmImage, Philippe Genne, PK profiling, preclinical anticancer drug evaluation, preclinical evaluation, preclinical evaluation anticancer therapies, preclinical evaluation anticancer therapy, preclinical evaluation of anticancer therapies, PREDICT, PREDICT platform, rat cancer model, rat cancer models, Scott Barksdale

Search

Services Healthcare Investors Database FAQs CGU Biotech & Pharma News Contact

Proudly powered by WordPress